BofA lowered the firm’s price target on Teladoc (TDOC) to $10.50 from $11.50 and keeps a Neutral rating on the shares. The firm, which notes it has been cautious on the trajectories of BetterHelp and Chronic care, looks for more detail on the pricing changes that may be taking place in the core business and lowered its price target based on lower peer multiples.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Study shows online therapy boom mostly benefited priviledged groups, NYT says
- Lilly cuts FY24 outlook, United Rentals to acquire H&E: Morning Buzz
- Unusually active option classes on open January 14th
- Morning Movers: H&E skyrockets following deal to be acquired by United Rentals
- Teladoc Jumps on Partnership with Amazon’s Health Benefits Connector